» Authors » Benjamin W Ewanchuk

Benjamin W Ewanchuk

Explore the profile of Benjamin W Ewanchuk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 121
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
MacKay S, Ewanchuk B, McIsaac M
BMJ Case Rep . 2024 Oct; 17(10). PMID: 39414322
is a ubiquitous bacterium and opportunistic pathogen for immunocompromised patients. Peritoneal dialysis-related peritonitis is a rare clinical presentation, with a total of 23 cases reported to date and an overall...
2.
Eftekhari R, Ewanchuk B, Rawji K, Yates R, Noorbakhsh F, Kuipers H, et al.
J Pharmacol Exp Ther . 2023 Sep; 388(1):12-22. PMID: 37699708
Proteinase-activated receptor-2 (PAR2), which modulates inflammatory responses, is elevated in the central nervous system in multiple sclerosis (MS) and in its murine model, experimental autoimmune encephalomyelitis (EAE). In PAR2-null mice,...
3.
Stukalin I, Navani V, Gupta M, Ruan Y, Boyne D, OSullivan D, et al.
Oncologist . 2023 Apr; 28(9):812-822. PMID: 37011230
Background: Risk stratification tools for patients with advanced melanoma (AM) treated with immune checkpoint inhibitors (ICI) are lacking. We identified a new prognostic model associated with overall survival (OS). Patients...
4.
Watson A, Goutam S, Stukalin I, Ewanchuk B, Sander M, Meyers D, et al.
JAMA Netw Open . 2022 Dec; 5(12):e2245596. PMID: 36480204
Importance: Immune-related adverse events (irAEs) due to immune checkpoint blockade (ICB) have been shown to be positively associated with survival. Among patients with metastatic melanoma, evidence supporting this association has...
5.
Greene C, Nguyen J, Cheung S, Arnold C, Balce D, Wang Y, et al.
Nat Commun . 2022 Jun; 13(1):3072. PMID: 35654768
Recognition of pathogen-or-damage-associated molecular patterns is critical to inflammation. However, most pathogen-or-damage-associated molecular patterns exist within intact microbes/cells and are typically part of non-diffusible, stable macromolecules that are not optimally...
6.
Gan C, Stukalin I, Meyers D, Dudani S, Grosjean H, Dolter S, et al.
Eur J Cancer . 2021 May; 151:115-125. PMID: 33975059
Background: Immuno-oncology (IO)-based therapies have been approved based on randomised clinical trials, yet a significant proportion of real-world patients are not represented in these trials. We sought to compare the...
7.
Ewanchuk B, Arnold C, Balce D, Premnath P, Orsetti T, Warren A, et al.
Sci Adv . 2021 Apr; 7(17). PMID: 33893096
The extracellular bone resorbing lacuna of the osteoclast shares many characteristics with the degradative lysosome of antigen-presenting cells. γ-Interferon-inducible lysosomal thiol reductase (GILT) enhances antigen processing within lysosomes through direct...
8.
Schubert C, Tjong J, Ewanchuk B, Moore R, Hollenberg M, Rabi D
Clin Invest Med . 2021 Mar; 44(1):E42-57. PMID: 33743576
On November 8th, 2019, the Cumming School of Medicine at the University of Calgary hosted the 11th annual Leaders in Medicine (LIM) Research Symposium. Dr. Donald A. Redelmeier, Professor at...
9.
Sander M, Stukalin I, Vallerand I, Goutam S, Ewanchuk B, Meyers D, et al.
Cancer Med . 2021 Mar; 10(8):2618-2626. PMID: 33724676
Background: Metastatic uveal melanoma (MUM) is associated with poor survival and inferior response to immune checkpoint inhibitor (ICI) therapy when compared with metastatic cutaneous melanoma. Currently, prognostic biomarkers are lacking...
10.
Ewanchuk B, Gharagozloo M, Peelen E, Pilutti L
Mult Scler Relat Disord . 2018 Sep; 26:19-32. PMID: 30216755
Introduction: Vascular comorbidities are prevalent among people with multiple sclerosis (MS) and have adverse disease-related consequences. In the general population, physical activity (PA) and exercise training have proven beneficial at...